Financing Quarterly Statistics, Q2 2021
A Look At Financing Activity Across The Biopharma, Medical Device And In Vitro Diagnostics Industries, April-June 2021
Executive Summary
For the second quarter of 2021, biopharmas brought in an aggregate $42.2bn in financing and device company fundraising totaled $3.1bn; while in vitro diagnostic firms and research tools players raised $5bn.